Taiwan-based CRO highlights cross-regional collaboration and global expansion strategies
Taipei, Taiwan — June 27, 2025 ClinHope, a leading Taiwan-based clinical research organization (CRO), announced that its Chief Executive Officer, Ms. Abby Chang, was invited to speak at the CBA-China (China Biotech Alliance – China) Summit in Hangzhou. In her keynote presentation, titled "A Global Perspective: Challenges and Opportunities in the Globalization of Clinical Trials," Ms. Chang shared ClinHope’s international strategies for driving clinical innovation and operational excellence.
Ms. Chang detailed how ClinHope supports global pharmaceutical, medical device, and nutraceutical companies by leveraging an efficient CRO model and cross-border infrastructure. Since establishing its U.S. branch in 2023, ClinHope has implemented a fully integrated collaboration system encompassing clinical operations, medical writing, regulatory submission, and data management across multiple regions.
“Establishing robust international communication and quality assurance systems is central to our mission of becoming a regional CRO leader in Asia,” said Abby Chang, CEO of ClinHope.
During the Q&A session, Ms. Chang highlighted current trends in clinical research talent development and encouraged young scientists to explore opportunities within the CRO industry. She also announced that ClinHope welcomes internship and partnership opportunities, extending an invitation to top talent from China and Taiwan to join its globally oriented and inclusive team.